Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response
Yongjun Sui, … , Robert C. Gallo, Jay A. Berzofsky
Yongjun Sui, … , Robert C. Gallo, Jay A. Berzofsky
Published February 18, 2019
Citation Information: J Clin Invest. 2019;129(3):1314-1328. https://doi.org/10.1172/JCI122110.
View: Text | PDF
Research Article Article has an altmetric score of 3

Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response

  • Text
  • PDF
Abstract

It is widely believed that protection against acquisition of HIV or SIV infection requires anti-envelope (anti-Env) antibodies, and that cellular immunity may affect viral loads but not acquisition, except in special cases. Here we provide evidence to the contrary. Mucosal immunization may enhance HIV vaccine efficacy by eliciting protective responses at portals of exposure. Accordingly, we vaccinated macaques mucosally with HIV/SIV peptides, modified vaccinia Ankara–SIV (MVA-SIV), and HIV-gp120–CD4 fusion protein plus adjuvants, which consistently reduced infection risk against heterologous intrarectal SHIVSF162P4 challenge, both high dose and repeated low dose. Surprisingly, vaccinated animals exhibited no anti-gp120 humoral responses above background and Gag- and Env-specific T cells were induced but failed to correlate with viral acquisition. Instead, vaccine-induced gut microbiome alteration and myeloid cell accumulation in colorectal mucosa correlated with protection. Ex vivo stimulation of the myeloid cell–enriched population with SHIV led to enhanced production of trained immunity markers TNF-α and IL-6, as well as viral coreceptor agonist MIP1α, which correlated with reduced viral Gag expression and in vivo viral acquisition. Overall, our results suggest mechanisms involving trained innate mucosal immunity together with antigen-specific T cells, and also indicate that vaccines can have critical effects on the gut microbiome, which in turn can affect resistance to infection. Strategies to elicit similar responses may be considered for vaccine designs to achieve optimal protective efficacy.

Authors

Yongjun Sui, George K. Lewis, Yichuan Wang, Kurt Berckmueller, Blake Frey, Amiran Dzutsev, Diego Vargas-Inchaustegui, Venkatramanan Mohanram, Thomas Musich, Xiaoying Shen, Anthony DeVico, Timothy Fouts, David Venzon, James Kirk, Robert C. Waters, James Talton, Dennis Klinman, John Clements, Georgia D. Tomaras, Genoveffa Franchini, Marjorie Robert-Guroff, Giorgio Trinchieri, Robert C. Gallo, Jay A. Berzofsky

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 Total
Citations: 1 3 1 6 7 7 2 27
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (27)

Title and authors Publication Year
Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge
Chege GK, Chapman RE, Keyser AT, Adams CH, Benn K, van Diepen MT, Douglass N, Lambson B, Hermanus T, Moore PL, Williamson AL
Viruses 2025
Innate protection against intrarectal SIV acquisition by a live SHIV vaccine.
Sui Y, Meyer TJ, Fennessey CM, Keele BF, Dadkhah K, Ma C, LaBranche CC, Breed MW, Kramer JA, Li J, Howe SE, Ferrari G, Williams LD, Cam M, Kelly MC, Shen X, Tomaras GD, Montefiori D, Greten TF, Miller CJ, Berzofsky JA
JCI insight 2024
Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response
Rahman MA, Bissa M, Scinto H, Howe SE, Sarkis S, Ma ZM, Gutowska A, Jiang X, Luo CC, Schifanella L, Moles R, Silva de Castro I, Basu S, N\u2019guessan KF, Williams LD, Becerra-Flores M, Doster MN, Hoang T, Choo-Wosoba H, Woode E, Sui Y, Tomaras GD, Paquin-Proulx D, Rao M, Talton JD, Kong XP, Zolla-Pazner S, Cardozo T, Franchini G, Berzofsky JA
Nature Communications 2024
Innate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications
Capriotti Z, Klase Z
Journal of Neurovirology 2024
SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy
Sui Y, Andersen H, Li J, Hoang T, Minai M, Nagata BM, Bock KW, Alves DA, Lewis MG, Berzofsky JA
Vaccine 2023
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges
S Lakhashe, M Amacker, D Hariraju, H Vyas, K Morrison, J Weiner, M Ackerman, V Roy, G Alter, G Ferrari, D Montefiori, G Tomaras, S Sawant, N Yates, C Gast, S Fleury, R Ruprecht
Frontiers in immunology 2022
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
A Borgognone, M Noguera-Julian, B Oriol, L Noël-Romas, M Ruiz-Riol, Y Guillén, M Parera, M Casadellà, C Duran, M Puertas, F Català-Moll, M Leon, S Knodel, K Birse, C Manzardo, J Miró, B Clotet, J Martinez-Picado, J Moltó, B Mothe, A Burgener, C Brander, R Paredes, S Benet, C Brander, S Cedeño, B Clotet, P Coll, A Llano, J Martinez-Picado, M Marszalek, S Morón-López, B Mothe, R Paredes, M Puertas, M Rosás-Umbert, M Ruiz-Riol, R Escrig, S Gel, M López, C Miranda, J Moltó, J Muñoz, N Perez-Alvarez, J Puig, B Revollo, J Toro, A Barriocanal, C Perez-Reche, M Farré, M Valle, C Manzardo, J Ambrosioni, I Ruiz, C Rovira, C Hurtado, C Ligero, E Fernández, S Sánchez-Palomino, J Miró, A Carrillo, M Meulbroek, F Pujol, J Saz, N Borthwick, A Crook, E Wee, T Hanke
Microbiome 2022
Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses
P Klasse, J Moore, G Silvestri
Journal of virology 2022
Trained Immunity and HIV Infection
Sviridov D, Miller YI, Bukrinsky MI
Frontiers in immunology 2022
An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques
Sui Y, Li J, Andersen H, Zhang R, Prabhu SK, Hoang T, Venzon D, Cook A, Brown R, Teow E, Velasco J, Pessaint L, Moore IN, Lagenaur L, Talton J, Breed MW, Kramer J, Bock KW, Minai M, Nagata BM, Choo-Wosoba H, Lewis MG, Wang LX, Berzofsky JA
2022
Myeloid-derived suppressor cells and vaccination against pathogens
Prochetto E, Borgna E, Jiménez-Cortegana C, Sánchez-Margalet V, Cabrera G
Frontiers in Cellular and Infection Microbiology 2022
Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques
Yongjun Sui, Jianping Li, Roushu Zhang, Sunaina K. Prabhu, Hanne Andersen Elyard, David Venzon, Anthony Cook, Renita Elizabeth Brown, Jason Velasco, Elyse Teow, Jack Greenhouse, Tammy Putmon-Taylor, Tracey-Ann V Campbell, Laurent Pessaint, Ian Moore, Laurel A. Lagenaur, James D. Talton, Matthew W Breed, Joshua Kramer, Kevin W. Bock, Mahnaz Minai, Bianca M. Nagata, Mark G. Lewis, Lai-Xi Wang, Jay A. Berzofsky
JCI Insight 2021
Microbiome Studies in Non-human Primates
JM Brenchley, AM Ortiz
Current HIV/AIDS Reports 2021
SARS-CoV-2 Spike Protein Suppresses ACE2 and Type I Interferon Expression in Primary Cells From Macaque Lung Bronchoalveolar Lavage
Y Sui, J Li, DJ Venzon, JA Berzofsky
Frontiers in immunology 2021
Sublingual Immunization with Chimeric C1q/CD40 Ligand/HIV Virus-Like Particles Induces Strong Mucosal Immune Responses against HIV
D Liu, S Zhang, E Poteet, C Marin-Muller, C Chen, Q Yao
Human vaccines 2021
Circulation of human coronaviruses OC43 and 229E in Córdoba, Argentina
ME Ottogalli, PE Rodríguez, MC Frutos, LB Moreno, LM Ghietto, CG Cuffini, JA Cámara, MP Adamo, LE Valinotto, A Cámara
Archives of Virology 2021
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial
JV Chua, C Davis, JS Husson, A Nelson, I Prado, R Flinko, KW Lam, L Mutumbi, BT Mayer, D Dong, W Fulp, C Mahoney, M Gerber, R Gottardo, BL Gilliam, K Greene, H Gao, N Yates, G Ferrari, G Tomaras, D Montefiori, JA Schwartz, T Fouts, AL DeVico, GK Lewis, RC Gallo, MM Sajadi
Vaccine 2021
Virus Control in Vaccinated Rhesus Macaques Is Associated with Neutralizing and Capturing Antibodies against the SHIV Challenge Virus but Not with V1V2 Vaccine–Induced Anti-V2 Antibodies Alone
AJ Hessell, L Li, DC Malherbe, P Barnette, S Pandey, W Sutton, D Spencer, XH Wang, JS Gach, R Hunegnaw, M Tuen, X Jiang, CC Luo, CC LaBranche, Y Shao, DC Montefiori, DN Forthal, R Duerr, M Robert-Guroff, NL Haigwood, MK Gorny
Journal of immunology (Baltimore, Md. : 1950) 2021
Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus
Anca Dorhoi, Leigh A. Kotze, Jay A. Berzofsky, Yongjun Sui, Dmitry I. Gabrilovich, Ankita Garg, Richard Hafner, Shabaana A. Khader, Ulrich E. Schaible, Stefan H.E. Kaufmann, Gerhard Walzl, Manfred B. Lutz, Robert N. Mahon, Suzanne Ostrand-Rosenberg, William R. Bishai, Nelita du Plessis
Journal of Clinical Investigation 2020
HIV vaccines: Unmasking myeloid derived suppressor cells
WR Green, MA O'Connor
EBioMedicine 2020
Myeloid Cell-Mediated Trained Innate Immunity in Mucosal AIDS Vaccine Development
Y Sui, JA Berzofsky
Frontiers in immunology 2020
Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development
ST Pasco, J Anguita
Cells 2020
Search for antiviral functions of potentially protective antibodies against V2 region of HIV-1
MK Gorny
Human Vaccines & Immunotherapeutics 2020
Does Mucosal B1 Activation Result in the Accumulation of Peak IgM During Chronic Intrarectal SIVmac239 Exposure to Protect Chinese-Origin Rhesus Macaques From Disease Progression?
Z Cong, L Tong, Y Wang, A Su, T Chen, Q Wei, J Xue, C Qin
Frontiers in microbiology 2020
A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post-Simian Immunodeficiency Virus Infection in Male and Female Rhesus Macaques
T Musich, V Thovarai, DJ Venzon, V Mohanram, I Tuero, LK Miller-Novak, SH Hait, MA Rahman, R Hunegnaw, E Huiting, W Yuan, C OhUigin, T Hoang, Y Sui, C LaBranche, D Montefiori, J Bear, M Rosati, M Bissa, JA Berzofsky, GN Pavlakis, BK Felber, G Franchini, M Robert-Guroff, G Silvestri
Journal of virology 2020
Systems serology for decoding infection and vaccine-induced antibody responses to HIV-1:
S Pittala, KS Morrison, ME Ackerman
Current Opinion in HIV and AIDS 2019
Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination
JA Cram, AJ Fiore-Gartland, S Srinivasan, S Karuna, G Pantaleo, GD Tomaras, DN Fredricks, JG Kublin, E Morgan
PloS one 2019

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 6 X users
47 readers on Mendeley
See more details